News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,585 Results
Type
Article (42024)
Company Profile (331)
Press Release (667230)
Section
Business (210219)
Career Advice (2083)
Deals (36601)
Drug Delivery (100)
Drug Development (82891)
Employer Resources (171)
FDA (16509)
Job Trends (15369)
News (355598)
Policy (33840)
Tag
Academia (2574)
Alliances (51266)
Alzheimer's disease (1308)
Approvals (16470)
Artificial intelligence (178)
Bankruptcy (364)
Best Places to Work (11737)
Biotechnology (213)
Breast cancer (207)
Cancer (1557)
Cardiovascular disease (128)
Career advice (1742)
CAR-T (108)
Cell therapy (318)
Clinical research (66489)
Collaboration (591)
Compensation (312)
COVID-19 (2621)
C-suite (136)
Data (1483)
Diabetes (193)
Diagnostics (6287)
Earnings (86724)
Employer resources (149)
Events (113231)
Executive appointments (502)
FDA (17298)
Funding (526)
Gene therapy (227)
GLP-1 (658)
Government (4460)
Healthcare (18922)
Infectious disease (2718)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16671)
Job creations (4054)
Job search strategy (1488)
Layoffs (445)
Legal (8337)
Lung cancer (228)
Manufacturing (224)
Medical device (13321)
Medtech (13326)
Mergers & acquisitions (20184)
Metabolic disorders (514)
Neuroscience (1683)
NextGen: Class of 2025 (6631)
Non-profit (4519)
Northern California (1882)
Obesity (293)
Opinion (211)
Patents (137)
People (58618)
Phase I (20606)
Phase II (29255)
Phase III (21927)
Pipeline (618)
Postmarket research (2652)
Preclinical (8740)
Radiopharmaceuticals (244)
Rare diseases (302)
Real estate (6244)
Regulatory (22641)
Research institute (2361)
Resumes & cover letters (358)
Southern California (1626)
Startups (3716)
United States (16883)
Vaccines (599)
Weight loss (210)
Date
Today (105)
Last 7 days (424)
Last 30 days (1968)
Last 365 days (35350)
2025 (1847)
2024 (35809)
2023 (40633)
2022 (51799)
2021 (56329)
2020 (54796)
2019 (47401)
2018 (35772)
2017 (33140)
2016 (32664)
2015 (38619)
2014 (32519)
2013 (27632)
2012 (29734)
2011 (30489)
2010 (28497)
Location
Africa (776)
Arizona (210)
Asia (40281)
Australia (6444)
California (4288)
Canada (1568)
China (372)
Colorado (196)
Connecticut (208)
Europe (85738)
Florida (610)
Georgia (147)
Illinois (424)
Indiana (250)
Maryland (695)
Massachusetts (3341)
Michigan (185)
Minnesota (319)
New Jersey (1206)
New York (1212)
North Carolina (808)
Northern California (1882)
Ohio (155)
Pennsylvania (1007)
South America (1159)
Southern California (1626)
Texas (631)
Utah (122)
Washington State (435)
709,585 Results for "wex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions
WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that it has commenced its Quantitative Sensory Testing (QST) clinical trial and is actively recruiting participants into this clinical trial.
December 11, 2023
·
5 min read
Drug Development
Wex Pharmaceuticals Inc. Enrolls the First Patient in The Phase 2b Clinical Trial Evaluating the Efficacy and Safety of Halneuron(R) In the Treatment of Chemotherapy-Induced Neuropathic Pain
WEX Pharmaceuticals Inc., a biotechnology company developing Halneuron® for pain, announced that the first patient has been dosed in its Phase 2B clinical trial evaluating the efficacy and safety of Tetrodotoxin in the treatment of Chemotherapy-Induced Neuropathic Pain.
January 3, 2023
·
6 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules
January 22, 2025
·
2 min read
Press Releases
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
December 3, 2024
·
2 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
1 of 70,959
Next
